ARKG 08/29/2024

ARK publishes a holdings file for each trading day that records how many shares each fund owns. The Shares Held column draws from these files: it displays today’s share count, and the number in parentheses shows the difference obtained by comparing today’s file with the previous trading day’s file.

#DateCompanyTickerCUSIPWeightShares HeldMarket Value
108/29/2024TWIST BIOSCIENCE CORPTWST90184D1008.25%2,545,287 (-2,445) (-0.1%)$112,425,326.79
208/29/2024CAREDX INCCDNA14167L1036.83%3,076,751 (-2,956) (-0.1%)$93,040,950.24
308/29/2024RECURSION PHARMACEUTICALS-ARXRX75629V1046.52%12,060,163 (-11,586) (-0.1%)$88,883,401.31
408/29/2024CRISPR THERAPEUTICS AGCRSPH171821086.13%1,759,230 (-1,690) (-0.1%)$83,528,240.40
508/29/2024INTELLIA THERAPEUTICS INCNTLA45826J1054.95%3,018,298 (-2,900) (-0.1%)$67,458,960.30
608/29/2024IONIS PHARMACEUTICALS INCIONS4622221004.80%1,329,574 (-1,278) (-0.1%)$65,481,519.50
708/29/2024VERACYTE INCVCYT92337F1074.18%1,800,886 (-1,730) (-0.1%)$56,944,015.32
808/29/202410X GENOMICS INC-CLASS ATXG88025U1094.11%2,515,151 (-2,416) (-0.1%)$56,062,715.79
908/29/2024NURIX THERAPEUTICS INCNRIX67080M1034.05%2,201,225 (-2,115) (-0.1%)$55,228,735.25
1008/29/2024ADAPTIVE BIOTECHNOLOGIESADPT00650F1093.81%11,521,640 (-11,069) (-0.1%)$51,962,596.40
1108/29/2024BEAM THERAPEUTICS INCBEAM07373V1053.70%1,937,690 (-1,862) (-0.1%)$50,476,824.50
1208/29/2024SCHRODINGER INCSDGR80810D1033.48%2,321,034 (-2,230) (-0.1%)$47,488,355.64
1308/29/2024TEMPUS AI INCTEM88023B1033.27%752,653 (-352) (-0.05%)$44,579,637.19
1408/29/2024NATERA INCNTRA6323071043.25%372,928 (-359) (-0.1%)$44,307,575.68
1508/29/2024ARCTURUS THERAPEUTICS HOLDINARCT UQ03969T1093.19%2,086,795 (-2,005) (-0.1%)$43,488,807.80
1608/29/2024PERSONALIS INCPSNL71535D1062.48%6,123,187 (-5,883) (-0.1%)$33,861,224.11
1708/29/2024VEEVA SYSTEMS INC-CLASS AVEEV9224751082.33%159,083 (-153) (-0.1%)$31,713,196.05
1808/29/2024GUARDANT HEALTH INCGH40131M1092.27%1,178,738 (-1,133) (-0.1%)$30,882,935.60
1908/29/2024MODERNA INCMRNA60770K1072.21%384,487 (-370) (-0.1%)$30,128,401.32
2008/29/2024VERTEX PHARMACEUTICALS INCVRTX92532F1002.04%56,788 (-55) (-0.1%)$27,810,787.24
2108/29/2024ABSCI CORPABSI00091E1091.88%5,849,011 (77,129) (1.34%)$25,677,158.29
2208/29/2024AMGEN INCAMGN0311621001.84%76,086 (-73) (-0.1%)$25,069,576.14
2308/29/2024ACCOLADE INCACCD00437E1021.66%5,347,278 (-5,137) (-0.1%)$22,565,513.16
2408/29/2024STANDARD BIOTOOLS INCLAB34385P1081.36%8,889,793 (-8,541) (-0.1%)$18,490,769.44
2508/29/2024REGENERON PHARMACEUTICALSREGN75886F1071.32%15,046 (-14) (-0.09%)$18,044,517.34
2608/29/2024EXACT SCIENCES CORPEXAS30063P1051.26%280,812 (-270) (-0.1%)$17,171,653.80
2708/29/2024CERUS CORPCERS1570851011.25%7,583,284 (-7,285) (-0.1%)$16,986,556.16
2808/29/2024PACIFIC BIOSCIENCES OF CALIFPACB69404D1081.21%12,179,141 (-11,700) (-0.1%)$16,441,840.35
2908/29/2024COMPASS PATHWAYS PLCCMPS20451W1011.15%1,991,955 (-1,914) (-0.1%)$15,736,444.50
3008/29/2024INCYTE CORPINCY45337C1021.01%210,030 (-202) (-0.1%)$13,786,369.20
3108/29/2024908 DEVICES INCMASS65443P1021.00%3,399,821 (-5,213) (-0.15%)$13,565,285.79
3208/29/2024PRIME MEDICINE INCPRME74168J1010.87%2,803,697 (-2,694) (-0.1%)$11,831,601.34
3308/29/2024QUANTUM-SI INCQSI74765K1050.82%11,769,198 (-11,307) (-0.1%)$11,197,214.98
3408/29/2024BUTTERFLY NETWORK INCBFLY1241551020.73%10,075,546 (-9,680) (-0.1%)$9,952,624.34
3508/29/2024REPARE THERAPEUTICS INCRPTX7602731020.55%2,492,581 (-2,395) (-0.1%)$7,527,594.62
3608/29/2024GOLDMAN FS TRSY OBLIG INST 468X9USDGSFT0.20%2,749,558 (1,215,642) (79.25%)$2,749,557.79
3708/29/2024SENTI BIOSCIENCES INCSNTI81726A2090.03%172,225 (-166) (-0.1%)$442,618.25
3808/29/2024GINKGO BIOWORKS HOLDINGS INCDNA U37611X2090.00%0 (-89) (-100%)$0.00
3908/29/2024TELADOC HEALTH INCTDOC87918A1050.00%0 (-202) (-100%)$0.00
4008/29/2024VERVE THERAPEUTICS INCVERV92539P1010.00%2,673 (-24,820) (-90.28%)$15,690.51
Source: https://assets.ark-funds.com/fund-documents/funds-etf-csv/ARK_GENOMIC_REVOLUTION_ETF_ARKG_HOLDINGS.csv

Discover more from ARK Invest Daily Trades Tracker

Subscribe to get the latest posts sent to your email.

Leave a Comment